Eli Lilly and Company

Associate-Sr. Associate-Manager - Social Listening & Data Analytics

Chester, Maryland, United States

Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, PharmaceuticalsIndustries

Requirements

The ideal candidate will possess a strong understanding of social media analytics tools and methodologies, with the ability to synthesize findings into actionable insights. A proven track record in social listening, data analysis, and strategic storytelling is essential, along with experience presenting complex analytical reports to stakeholders. Familiarity with healthcare customer insights and competitive analysis is also required.

Responsibilities

This role is responsible for serving as the social listening subject matter expert, providing data-driven insights to meet business objectives and delivering strategic social insights to internal brand and Medical Affairs teams. Key duties include maintaining and updating social listening queries, synthesizing findings from social media sources, and creating meaningful insights with clear implications for action. The position also involves leveraging social media listening tools to generate timely research and reporting on customer insights, competitive analysis, product insights, and emerging trends, presenting these findings to multiple Lilly product brands and internal stakeholders.

Skills

Social Listening
Data Analytics
Customer Experience
Digital Marketing
Social Media Strategy
Data Analysis
Communication

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI